Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Scalable 3D cell-interaction analysis via supercell graphs for prostate cancer risk stratification

Created on 12 Jul 2026

Authors

Zhao, Y., Chow, S. S. L., Yan, R., Brenes, D., Serafin, R., Almagro-Perez, C., Song, A. H., Lal, P., Chan, E., Downes, M., Baraznenok, E., Lopez, J. S., Madabhush, A., Mahmood, F., True, L. D., Liu, J. T. C.

Abstract

Cellular interactions underlie fundamental biological processes but are not fully represented in conventional 2D histology images. While 3D pathology allows for more-accurate construction of cell-level graphs, machine-learning models are computationally unwieldy and prone to overfitting, especially when dealing with small cohorts. Here, we introduce SCALE3D, a SuperCell graph Analysis framework for LargE 3D pathology datasets. In SCALE3D, spatially adjacent and morphologically similar cells are grouped into functional supercells. Supercell subtypes are defined via morphology-based clustering and 3D graphs connecting these supercells are used to model their interactions. Validation was performed with 76 radical prostatectomy specimens from patients with known 5-year biochemical recurrence (BCR) outcomes. SCALE3D-derived features achieve higher performance for BCR prediction than established 3D nuclear and glandular morphological features. Combining these complementary features further improves prediction performance. Compared to individual cell-level 3D graphs, SCALE3D maintains comparable prognostic performance with improved noise tolerance while reducing computational times by up to 1,000-fold.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 12 Jul 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement